Cancer

Neoadjuvant chemotherapy key to survival in pancreatic cancer

(HealthDay)—Three factors can predict survival in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 2 in the Annals of ...

Cancer

Variation in cancer-causing KRAS mutations greater than thought

The effects of KRAS mutations underlying many different types of cancer are more diverse than previously thought, according to a new study led by the University of Eastern Finland. Different mutations in the same amino acid ...

Cancer

Organoid profiling identifies treatments for pancreatic cancer

Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond to a variety of treatments, facilitating a precision-medicine approach ...

page 1 from 7